NanoViricides Inc (NNVC)

10:56 AM

Press Release Distribution & PR Platform - ACCESS Newswire

10:56 AM

Apr 24, 2025

Nanostructured Drug Market Projected for Significant Expansion by 2032 -Nanoviricides Inc, Ablynx NV, Pfizer - newstrail.com

Apr 24, 2025

Apr 14, 2025

Small cap wrap: Gunnison Copper, Ocean Power Technologies, NanoViricides... - Proactive financial news

Apr 14, 2025

Apr 14, 2025

NanoViricides evaluating antiviral drug NV-387 for measles treatment - Proactive financial news

Apr 14, 2025

Apr 14, 2025

Measles Outbreak Expands Begging for a Drug to Treat the InfectionNanoViricides Declares it is Ready to Fight the Outbreak - Lelezard

Apr 14, 2025

Apr 12, 2025

NanoViricides, Inc. Appoints Irach Taraporewala as the New CEO and Nominates to Serve as a Member of the Board of Directors - marketscreener.com

Apr 12, 2025

Apr 09, 2025

Nanostructured Drug Market Detailed In New Research Report 2025 | Nanoviricides Inc., Ablynx NV, Pfizer - newstrail.com

Apr 09, 2025

Apr 05, 2025

NanoViricides unaffected by US tariff turmoil, says CFO - Proactive financial news

Apr 05, 2025

Apr 05, 2025

NNVC stock touches 52-week low at $1.02 amid market challenges - Investing.com Canada

Apr 05, 2025

Apr 04, 2025

NanoViricides unimpacted by tariffs; sees boost by changes at government agencies - Proactive Investors

Apr 04, 2025

Apr 04, 2025

NNVC stock touches 52-week low at $1.02 amid market challenges By Investing.com - Investing.com South Africa

Apr 04, 2025

Apr 04, 2025

NanoViricides highlights broad-spectrum antiviral strategy and progress with lead drug candidate - Proactive financial news

Apr 04, 2025

Mar 31, 2025

Virtu Financial LLC Acquires New Position in NanoViricides, Inc. (NYSE:NNVC) - Defense World

Mar 31, 2025

Mar 28, 2025

Small cap wrap: NanoViricides, G Mining Ventures, Nevis Brands... - Proactive Investors

Mar 28, 2025

Mar 28, 2025

NanoViricides eyes role in US bird flu fight as USDA unveils $100M initiative - Proactive Investors

Mar 28, 2025

Mar 25, 2025

NanoViricides Has Initiated Bio-analytical Studies as Part of IND-Enabling Safety and Toxicology Studies of Lead Candidate NV-HHV-101 - ACCESS Newswire

Mar 25, 2025

Mar 15, 2025

NanoViricides (NYSE:NNVC) Trading Up 1.7% – Time to Buy? - Defense World

Mar 15, 2025

Mar 12, 2025

Stock Update - Investorsobserver

Mar 12, 2025

Mar 11, 2025

AllPennyStocks.com News: Junior Biotech Bounces off $1; Chart Trying to Turn Bullish - ACCESS Newswire

Mar 11, 2025

Mar 11, 2025

Market movers: Delta, Kohl's, Asana, NanoViricides... - Proactive Investors

Mar 11, 2025

Mar 11, 2025

NanoViricides says business unaffected by US tariffs, highlights antiviral pipeline - Proactive financial news

Mar 11, 2025

Mar 11, 2025

Nanoviricides Co's Business Not Affected By Tariff Policies Of Us Government Or Corresponding Retaliatory Policies Of Other Governments - Marketscreener.com

Mar 11, 2025

Mar 11, 2025

NanoViricides Not Affected by Tariffs and Other Policies, Has Excellent Long Term Outlook, Stock-Price Decline Misguided, Explains the Company - Jonesboro Sun

Mar 11, 2025

Mar 08, 2025

Springing into action in time of need: NanoViricides, Inc. (NNVC.OB) - ACCESS Newswire

Mar 08, 2025

Mar 04, 2025

Unicycive Therapeutics Inc (NASDAQ:UNCY) stock: Is this a flash in the pan today? - US Post News

Mar 04, 2025

Mar 04, 2025

Measles Outbreak: NV-387 Promises To Be An Effective Drug To Treat Patients; We are Ready To Work With HHS, Says NanoViricides President Dr. Anil Diwan - Lelezard

Mar 04, 2025

Mar 04, 2025

NanoViricides' NV-387 could provide a crucial missing weapon in the fight against US measles outbreak - Proactive financial news

Mar 04, 2025

Mar 04, 2025

Investornewsbreaks Nanoviricides (NYSE American: NNVC) Highlights NV-387 As Potential Measles Treatment Amid Outbreak - MENAFN.COM

Mar 04, 2025

Mar 01, 2025

NanoViricides Announces Pricing of $10.2 Million Registered Direct Offering - ACCESS Newswire

Mar 01, 2025

Feb 28, 2025

Mpox – a possible US$100mln+ opportunity - Proactive Investors USA

Feb 28, 2025

Feb 28, 2025

NanoViricides Successfully Completes Required Genetic Toxicology Testing of Lead Drug Candidate NV-HHV-101 - ACCESS Newswire

Feb 28, 2025

Feb 28, 2025

NanoViricides to Provide Corporate Update at the Spartan Capital Investors Conference 2024, Today at 9:45am - ACCESS Newswire

Feb 28, 2025

Feb 27, 2025

NanoViricides Has Filed Quarterly Report for Period Ending December 31, 2021Has Sufficient Cash, NV-CoV-2 Coronavirus Drug Candidate Clinical Trials Application Ready - ACCESS Newswire

Feb 27, 2025

Feb 27, 2025

NanoViricides Has Filed Quarterly Report for Period Ending March 31, 2020Has Sufficient Cash, Progress on New Coronavirus Drug Program and the Lead HerpeCide(TM) Drug Candidate IND Application - ACCESS Newswire

Feb 27, 2025

Feb 27, 2025

NanoViricides Receives Cash Infusion of $2.25 Million - ACCESS Newswire

Feb 27, 2025

Feb 27, 2025

NanoViricides Closes on $8.625 Million Underwritten Public Offering of Common Stock - ACCESS Newswire

Feb 27, 2025

Feb 27, 2025

NanoViricides Has Initiated Required Safety Pharmacology Assessment of Lead Drug Candidate towards IND - ACCESS Newswire

Feb 27, 2025

Feb 21, 2025

Small cap headlines: EnWave, NanoViricides, GoviEx, TNR Gold... - Proactive Investors UK

Feb 21, 2025

Feb 19, 2025

NanoViricides targets key milestones in 2025 with NV-387 advancing to Phase II trials - Proactive Investors USA

Feb 19, 2025

Feb 19, 2025

NanoViricides, Inc. Has Filed its Quarterly Report - Chronicle-Tribune

Feb 19, 2025

Feb 15, 2025

NanoViricides, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2024 - Marketscreener.com

Feb 15, 2025

Feb 14, 2025

NanoViricides Inc. (NNVC) reports earnings - Quartz

Feb 14, 2025

Feb 14, 2025

NanoViricides: Fiscal Q2 Earnings Snapshot - San Antonio Express-News

Feb 14, 2025